Fusion Antibodies plc announced that Sonya Ferguson, Non-executive Director, will not be seeking re-election at the AGM to be held on 27 October 2023, as she has decided to pursue another business opportunity. She will cease to be a Director of the Company at the close of the AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 GBX | -7.25% |
|
-4.48% | -24.71% |
05-23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
05-23 | Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.71% | 4.17M | |
+34.01% | 51.07B | |
+33.84% | 38.86B | |
-8.02% | 38.78B | |
-8.98% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- FAB Stock
- News Fusion Antibodies plc
- Fusion Antibodies plc Announces Sonya Ferguson, Non-Executive Director, Will Not Be Seeking Re-Election At the AGM